FFCP PHASE1:Mm9::chr13:30095274..30095283,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=18|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:30095274..30095283,+|id=chr13:30095274..30095283,+|ontology_enrichment_celltype=CL:0000553!1.02e-14!6;CL:0000556!1.02e-14!6;CL:0000050!1.06e-09!9;CL:0000414!7.18e-08!11|ontology_enrichment_celltype_v019_2=CL:0000553,8.31e-47,6;CL:0000556,8.31e-47,6;CL:0000050,1.59e-31,9;CL:0000839,4.28e-22,13;CL:0000945,1.74e-18,1;CL:0000236,1.74e-18,1;CL:0000826,1.74e-18,1;CL:0000763,4.18e-18,16;CL:0002031,5.10e-18,25;CL:0000049,2.28e-15,19;CL:0000988,3.12e-14,32;CL:0002032,3.12e-14,32;CL:0000037,3.12e-14,32;CL:0000837,3.12e-14,32;CL:0002320,4.29e-10,46;CL:0000134,4.29e-10,46;CL:0000219,1.10e-08,54;CL:0002027,5.46e-07,3;CL:0002006,5.46e-07,3;CL:0002024,5.46e-07,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0002371,4.18e-18,16;UBERON:0001474,2.26e-13,22;UBERON:0004765,2.26e-13,22;UBERON:0001434,2.26e-13,22;UBERON:0002384,4.29e-10,46;UBERON:0002204,2.11e-09,32;UBERON:0002390,7.45e-07,45;UBERON:0003061,7.45e-07,45|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.33243904726265,0.404950534779652,0,3.15462165358238,2.87940310572051,4.66828616977833,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.18117387875057,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279182999001381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.776813650941515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.292780797011547,0.209446706813455,0,0,0,0,0,0,0,0.347648640384553,0.255715457330331,0,0.162241263067758,0,0,0,0.420883711772948,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369506380333209,0,0,0,0,0,0,0,0,0,0.159454768657487,0.163863314715738,0,0,0,0,0,0,0,0.117211686592203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.683483523191411,0,0,0,0.136694227721025,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198681354781265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.685082519770642,0,0,0.45032120322422,0,0.51776031175182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:30095274..30095283,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=18 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:30095274..30095283,+ | |||
|description=CAGE_peak_at_chr13:30095274..30095283,+ | |||
|id=chr13:30095274..30095283,+ | |||
|ontology_enrichment_celltype=CL:0000553!1.02e-14!6;CL:0000556!1.02e-14!6;CL:0000050!1.06e-09!9;CL:0000414!7.18e-08!11 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,8.31e-47,6;CL:0000556,8.31e-47,6;CL:0000050,1.59e-31,9;CL:0000839,4.28e-22,13;CL:0000945,1.74e-18,1;CL:0000236,1.74e-18,1;CL:0000826,1.74e-18,1;CL:0000763,4.18e-18,16;CL:0002031,5.10e-18,25;CL:0000049,2.28e-15,19;CL:0000988,3.12e-14,32;CL:0002032,3.12e-14,32;CL:0000037,3.12e-14,32;CL:0000837,3.12e-14,32;CL:0002320,4.29e-10,46;CL:0000134,4.29e-10,46;CL:0000219,1.10e-08,54;CL:0002027,5.46e-07,3;CL:0002006,5.46e-07,3;CL:0002024,5.46e-07,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002371,4.18e-18,16;UBERON:0001474,2.26e-13,22;UBERON:0004765,2.26e-13,22;UBERON:0001434,2.26e-13,22;UBERON:0002384,4.29e-10,46;UBERON:0002204,2.11e-09,32;UBERON:0002390,7.45e-07,45;UBERON:0003061,7.45e-07,45 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.33243904726265,0.404950534779652,0,3.15462165358238,2.87940310572051,4.66828616977833,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.18117387875057,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.279182999001381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.776813650941515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.292780797011547,0.209446706813455,0,0,0,0,0,0,0,0.347648640384553,0.255715457330331,0,0.162241263067758,0,0,0,0.420883711772948,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369506380333209,0,0,0,0,0,0,0,0,0,0.159454768657487,0.163863314715738,0,0,0,0,0,0,0,0.117211686592203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.683483523191411,0,0,0,0.136694227721025,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198681354781265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.685082519770642,0,0,0.45032120322422,0,0.51776031175182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:30095274..30095283,+ | |||
}} |
Latest revision as of 21:13, 5 August 2015
Short description: | p@chr13:30095274..30095283, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:30095274..30095283, + |
Coexpression cluster: | MCL_coexpression_mm9:18 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 8.31e-47 | 6 |
megakaryocyte | 8.31e-47 | 6 |
megakaryocyte-erythroid progenitor cell | 1.59e-31 | 9 |
myeloid lineage restricted progenitor cell | 4.28e-22 | 13 |
lymphocyte of B lineage | 1.74e-18 | 1 |
B cell | 1.74e-18 | 1 |
pro-B cell | 1.74e-18 | 1 |
myeloid cell | 4.18e-18 | 16 |
hematopoietic lineage restricted progenitor cell | 5.10e-18 | 25 |
common myeloid progenitor | 2.28e-15 | 19 |
hematopoietic cell | 3.12e-14 | 32 |
hematopoietic oligopotent progenitor cell | 3.12e-14 | 32 |
hematopoietic stem cell | 3.12e-14 | 32 |
hematopoietic multipotent progenitor cell | 3.12e-14 | 32 |
connective tissue cell | 4.29e-10 | 46 |
mesenchymal cell | 4.29e-10 | 46 |
motile cell | 1.10e-08 | 54 |
CD9-positive, CD41-positive megakaryocyte cell | 5.46e-07 | 3 |
Kit-positive, CD34-negative megakaryocyte erythroid progenitor cell | 5.46e-07 | 3 |
Kit-positive megakaryocyte progenitor cell | 5.46e-07 | 3 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 4.18e-18 | 16 |
bone element | 2.26e-13 | 22 |
skeletal element | 2.26e-13 | 22 |
skeletal system | 2.26e-13 | 22 |
connective tissue | 4.29e-10 | 46 |
musculoskeletal system | 2.11e-09 | 32 |
hematopoietic system | 7.45e-07 | 45 |
blood island | 7.45e-07 | 45 |